ASBP
Income statement / Annual
Last year (2024), Aspire Biopharma Holdings Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Aspire Biopharma Holdings Inc.'s net income was -$12.54 M.
See Aspire Biopharma Holdings Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$144.36 K
|
$72.05 K
|
$175.32 K
|
$0.00
|
| General & Administrative Expenses |
$3.09 M
|
$1.34 M
|
$976.35 K
|
$27.79 K
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$3.09 M
|
$1.34 M
|
$976.35 K
|
$27.79 K
|
| Other Expenses |
-$144.36 K
|
-$72.05 K
|
-$175.32 K
|
-$2.32 K
|
| Operating Expenses |
$3.09 M
|
$1.34 M
|
$976.35 K
|
$25.48 K
|
| Cost And Expenses |
$3.09 M
|
$1.34 M
|
$976.35 K
|
$25.48 K
|
| Interest Income |
$548.68 K
|
$5.81 M
|
$4.32 M
|
$0.00
|
| Interest Expense |
-$892.00 K
|
$8.97 K
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$1.34 M
|
$0.00
|
$27.79 K
|
| EBITDA |
-$11.65 M |
$5.80 M |
$3.34 M |
-$25.48 K |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$9.45 M
|
$5.80 M
|
$4.32 M
|
$5.00
|
| Income Before Tax |
-$12.54 M
|
$4.46 M
|
$3.34 M
|
-$25.48 K
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
| Income Tax Expense |
$1.01 K
|
$0.00
|
$626.00
|
$0.00
|
| Net Income |
-$12.54 M
|
$4.46 M
|
$3.34 M
|
-$25.48 K
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
| EPS |
-0.38 |
0.0575 |
0.0275 |
-0.001025 |
| EPS Diluted |
-0.38 |
0.0575 |
-0.00325 |
-0.001025 |
| Weighted Average Shares Out |
$32.98 M
|
$76.72 M
|
$126.74 M
|
$25.00 M
|
| Weighted Average Shares Out Diluted |
$32.98 M
|
$76.72 M
|
$126.74 M
|
$25.00 M
|
| Link |
|
|
|
|
